Treatment of benign prostatic hyperplasia

Area of Science:

• Urology
• Gerontology

Background:

• Lower urinary tract symptoms (LUTS) are often associated with aging.
• Benign prostatic enlargement (BPE) and benign prostatic obstruction (BPO) are common causes of LUTS in aging men.
• Patient quality of life is significantly impacted by bothersome LUTS.

Purpose of the Study:

• To review the current understanding of LUTS in the context of aging.
• To discuss established and emerging treatment options for LUTS.
• To emphasize the importance of symptom management and quality of life.

Main Methods:

• Literature review of studies on LUTS, BPE, BPO, and aging.
• Analysis of current medical and surgical treatment modalities for LUTS.
• Evaluation of emerging minimally invasive treatment outcomes.

Main Results:

• LUTS may be a natural part of aging, not solely a result of BPE/BPO.
• Medical treatments include alpha blockers and 5-alpha reductase inhibitors for benign prostatic hyperplasia (BPH).
• Transurethral Resection of the Prostate (TURP) is the established surgical standard, with minimally invasive options showing promise.

Conclusions:

• LUTS management should prioritize symptom relief and patient quality of life.
• While BPH treatments are effective, aging itself is a significant factor in LUTS.
• Emerging minimally invasive procedures offer new therapeutic avenues for LUTS.